Skip to main content
. 2014 Oct 9;17(4):304–310. doi: 10.1111/hpb.12342

Table 1.

Patient demographics, peri- and post-operative course of patients who underwent laparoscopic and open liver resections for hepatocellular carcinoma

LLR n = 43 (%) OLR n = 86 (%) Combined n = 129 (%) P-value
Gender 0.110
 Male 29 (67.4) 69 (80.2) 98 (76.0)
 Female 14 (32.6) 17 (19.8) 31 (24.0)
Age at resection (years; median, range) 62.0 (30–86) 63.0 (34–84) 62.9 (30–86) 0.521
Underlying liver disease 0.100
 HBV 19 (44.2) 52 (60.5) 71 (55.0)
 HCV 13 (30.2) 18 (20.9) 31 (24.0)
 Other (NASH, alcohol, undetermined) 11 (25.6) 16 (18.6) 27 (20.9)
Child–Pugh 0.789
 A 41 (97.6) 81 (97.6) 122 (97.6)
 B 1 (2.4) 2 (2.4) 3 (2.4)
 Not available 1 3 4
Clavien–Dindo Classification 0.050
 Non-severe (Grade 1–2) 10 (100.0) 24 (72.7) 34 (79.1)
 Severe (Grade 3–4) 0 (0.0) 9 (27.3) 9 (20.9)
 No complication 32 52 84
 Not available 1 1 2
Type of hepatic resection
 1–2 segments 21 (48.8) 45 (52.3) 66 (51.2) 0.740
 2 + segments 22 (51.2) 41 (47.7) 63 (48.8)
Resection margin 1.000
 Positive 0 (0.0) 0 (0.0) 0 (0.0)
 Negative 43 (100.0) 86 (100.0) 129 (100.0)
 Not available 0 0 0
Estimated blood loss (ml; median, range) 300 (0–6500) 700 (0–3500) 600 (0–6500) 0.004
Incision to closure time (min; median, range) 170 (88–536) 197 (70–365) 194 (88–536) 0.610
Complications 0.067
 Yes 10 (23.3) 34 (39.5) 44 (34.1)
 No 33 (76.7) 52 (60.6) 85 (65.9)
Conversion
 Yes 6 (14.0) NA NA NA
 No 37 (86.0)
Admission to ICU 0.657
 Yes 3 (7.0) 8 (9.3) 11 (8.5)
 No 40 (93.0) 78 (90.7) 118 (91.5)
30-day readmission 0.010
 Yes 1 (2.3) 16 (18.6) 17 (13.2)
 No 42 (97.7) 70 (81.4) 112 (86.8)
ER visit in 3 months 0.267
 Yes 2 (4.7) 9 (10.5) 11 (8.5)
 No 41 (95.3) 77 (89.5) 118 (91.5)
Length of stay (days; median, range) 5 (3–51) 7 (5–77) 7 (3–77) <0.001

OLR, open liver resection; HBV, hepatitis B virus;HCV, hepatitis C virus; NASH, non-alcoholic steatohepatitis; ICU, intensive care unit.